Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:30 AM ET 8-K
Clinical Trial Data Vivani Medical, Inc. VANI

Vivani Medical Clinical Trial Data

Vivani Medical announced positive top-line results from its SLIM-1 Phase 1 trial evaluating NPM-139, a miniature semaglutide implant for chronic weight management. The trial demonstrated that NPM-139 was well-tolerated with no treatment-related adverse events and achieved weight loss of 0.79% over four weeks, comparable to the 0.82% observed in the Wegovy control group.

Term
4 weeks

“The third quarter and recent weeks mark a period of strong progress and forward momentum for Vivani. The top-line SLIM-1 results will be announced this week. We look forward to sharing those results with shareholders, industry peers, and the broader community of physicians and patients seeking less frequent dosing and the promise of potential improvements in convenience, medication adherence, and tolerability associated with GLP-1 therapies on the market and in clinical-stage development.”

Adam Mendelsohn, PhD, CEO

“Roughly half of patients don’t take their medications for chronic diseases as prescribed, and GLP-1 therapies are no exception. With NPM-139, we are designing a novel GLP-1 therapy that a patient could receive once or twice a year during a routine primary care visit.”

Adam Mendelsohn, PhD, CEO
8:16 AM ET 8-K
M&A Deal Trustmark Corp TRMK

Trustmark Signs $3.2B M&A Deal with Hancock Whitney Corporation

Trustmark Corporation has entered into a definitive agreement to merge with and into Hancock Whitney Corporation in an all-stock transaction valued at approximately $3.2 billion. The merger will create a premier Gulf South regional bank with approximately $58 billion in assets and is expected to close in the first quarter of 2027.

Value
$3.2B
Counterparty
Hancock Whitney Corporation
8:15 AM ET 8-K
Product Launch Data443 Risk Mitigation, Inc. ATDS

Data443 Risk Mitigation Product Launch

Data443 Risk Mitigation announced the commercial launch of its Convaa.ai™ enterprise AI collaboration platform on the Apple App Store. The application is specifically optimized for the iPhone Duo foldable smartphone, allowing multi-person live AI collaboration sessions on the device's 7.6-inch inner display.

8:10 AM ET 8-K
M&A Deal Silence Therapeutics plc SLN

Silence Therapeutics M&A Deal with Merck KGaA

Silence Therapeutics announced it has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. The transaction is expected to close in the first quarter of 2027, subject to customary closing conditions and shareholder approval. While the filing also contains Q3 2026 financial results, the pending acquisition is the primary material event for investors.

Counterparty
Merck KGaA
8:10 AM ET 8-K
M&A Deal Inflection Point Acquisition Corp. VII IPXG

Inflection Point Acquisition Corp. VII M&A Deal with Elroy Air, Inc.

Inflection Point Acquisition Corp. VII entered into a second amendment to its business combination agreement with Elroy Air, Inc. The amendment simplifies the stock exchange process by eliminating the requirement for letters of transmittal and updates the closing conditions regarding seller lock-up agreements for certain equity holders and employees.

Counterparty
Elroy Air, Inc.
8:06 AM ET 8-K
Capital Raise Prime Medicine, Inc. PRME

Prime Medicine Capital Raise of $144M

Prime Medicine, Inc. entered into an underwriting agreement for a public offering of 35,714,286 shares of common stock at $3.50 per share. The company also granted underwriters a 30-day option to purchase up to an additional 5,357,142 shares, bringing the total potential gross proceeds to approximately $143.75 million. Proceeds will be used to advance the company's Wilson disease and alpha-1 antitrypsin deficiency programs and for general corporate purposes.

Value
$144M
Counterparty
Jefferies LLC
8:02 AM ET 8-K
Research Collaboration Oncolytics Biotech Inc ONCY

Oncolytics Biotech Research Collaboration with Coherus Oncology, Inc.

Oncolytics Biotech entered into a clinical supply agreement with Coherus Oncology to evaluate pelareorep in combination with LOQTORZI (toripalimab-tpzi) for the treatment of squamous cell anal carcinoma (SCAC). The clinical study, expected to begin in Q1 2027, will target second-line patients who have progressed on standard-of-care treatments.

Counterparty
Coherus Oncology, Inc.
8:01 AM ET 8-K
M&A Deal Hancock Whitney Corp HWC

Hancock Whitney Signs $3.2B M&A Deal with Trustmark Corporation

Hancock Whitney Corporation (HWC) has entered into a definitive agreement to acquire Trustmark Corporation (TRMK) in an all-stock transaction valued at approximately $3.2 billion. The merger will create a premier Gulf South regional bank with approximately $58 billion in assets and is expected to close in late Q1 2027.

Value
$3.2B
Counterparty
Trustmark Corporation

“By bringing together two high-performing banks with shared values, complementary capabilities, and a relentless focus on client success, we create an organization that is stronger as one. This combination enhances our platform, expands growth opportunities, strengthens the core deposit franchise, and broadens the capabilities we deliver to consumer and business clients.”

John M. Hairston, President and CEO of Hancock Whitney

“Given the strong cultural alignment and complementary business lines between our two organizations, we believe this transaction will generate substantial value and meaningful benefits for our customers, shareholders, associates, and communities.”

Duane Dewey, President and CEO of Trustmark
7:56 AM ET 8-K
M&A Deal Iron Horse Acquisition II Corp. IRHO

Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.

Iron Horse Acquisition II Corp. (IRHO) and its merger target Electra Vehicles, Inc. (ELECTRA AI) announced a three-year partnership where Electra will serve as the Official Battery Intelligence Partner for Westbrook Racing at the E1 Miami GP. This update provides a strategic and marketing milestone for the companies as they work toward completing their previously announced business combination agreement dated April 21, 2026.

Counterparty
Electra Vehicles, Inc.
7:50 AM ET 8-K
Nasdaq/NYSE Compliance Notice Hydrofarm Holdings Group, Inc. HYFM

Hydrofarm Holdings Group Nasdaq/NYSE Compliance Notice

Hydrofarm Holdings Group, Inc. has regained compliance with Nasdaq's $2.5 million minimum stockholders’ equity requirement following a financial restructuring that eliminated $109 million in debt. The company remains subject to a Mandatory Panel Monitor for one year, during which any failure to satisfy the equity rule would result in an immediate delist notice without the opportunity to submit a new compliance plan.

Counterparty
Nasdaq
Term
through November 9, 2027

“We received notice from Nasdaq that we are in compliance on our stockholders’ equity, another milestone in our financial restructuring. With this confirmation, our organization is focused on profitable growth: our proprietary brands out of Eugene, the direct commercial sales channel that opened when the term loan was eliminated, and scaling logistics services under Project Agility. That’s where our 50th year starts.”

Bill Toler, Chairman and Chief Executive Officer
7:32 AM ET 8-K
M&A Deal Installed Building Products, Inc. IBP

Installed Building Products Signs $725M M&A Deal with 1981 Holdco, Inc.

Installed Building Products (IBP) acquired Old Dominion Group (ODG), a leading mechanical and industrial insulation installer, for a base purchase price of $725 million. The deal was funded with 60% cash and 40% IBP common stock, establishing a scaled commercial and industrial installation platform with approximately $420 million in combined LTM revenue. The acquisition increases IBP's commercial end-market exposure to approximately 28% of total revenue and is expected to be immediately accretive to adjusted EPS.

Value
$725M
Counterparty
1981 Holdco, Inc. (Old Dominion Group)
7:31 AM ET 8-K
Licensing Deal Vor Biopharma Inc. VOR

Vor Biopharma Licensing Deal with RemeGen Co., Ltd. Worth $10M

Vor Biopharma expanded its existing partnership with RemeGen by entering into an amended and restated license agreement to add RC298, a next-generation dual BAFF/APRIL inhibitor, to its exclusive development and commercialization rights outside of Greater China. Vor Bio will pay an upfront cash payment of $10 million and issue a pre-funded warrant for 2.3 million shares, with RemeGen eligible for up to $630 million in development and regulatory milestones plus tiered royalties.

Value
$10M
Counterparty
RemeGen Co., Ltd.
7:01 AM ET 8-K
Capital Raise Southport Acquisition Corp. II PORT

Southport Acquisition Corp. II Capital Raise

Southport Acquisition Corp. II announced that holders of units issued in its initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting November 16, 2026. The separated securities will trade on the NYSE under the symbols 'PORT' and 'PORT WS', while unseparated units will continue to trade under 'PORT U'.

7:01 AM ET 8-K
Clinical Trial Data Traws Pharma, Inc. TRAW

Traws Pharma Clinical Trial Data

Traws Pharma announced final Phase 2a results for Ratutrelvir, showing symptom resolution comparable to PAXLOVID with no viral rebound and fewer treatment-related adverse events in COVID-19 patients. The company also completed a bridging study for Tivoxavir Marboxil (TXM), supporting its potential as a once-monthly influenza prophylactic agent.

6:55 AM ET 8-K
M&A Deal Spectrum Brands Holdings, Inc. SPB

Spectrum Brands Holdings Signs $1.6B M&A Deal with Helen of Troy Limited

Spectrum Brands' joint venture, Empower Brands, issued an open letter and investor presentation to Helen of Troy (HELE) shareholders regarding its $37.00 per share all-cash acquisition proposal. The offer values Helen of Troy at an enterprise value of approximately $1.6 billion and represents a premium to the target's standalone trading price. Empower Brands, which owns 4.5% of HELE, is urging the board to engage after multiple rejections of its consolidation proposal.

Value
$1.6B
Counterparty
Helen of Troy Limited
6:31 AM ET 8-K
M&A Deal Arko Petroleum Corp. APC

Arko Petroleum Signs $230M M&A Deal with U.S. Petroleum Partners, LLC

ARKO Petroleum Corp. completed its acquisition of the assets of U.S. Petroleum Partners, LLC, a fuel supply and distribution platform in the Great Lakes region. The consideration consisted of $200 million in cash plus approximately 2 million shares of Class A common stock valued at $30 million, which are subject to EBITDA-based earn-out targets for 2027. The deal includes two fuel terminals and supply rights to approximately 400 dealer locations.

Value
$230M
Counterparty
U.S. Petroleum Partners, LLC
6:30 AM ET 8-K
M&A Deal Arko Corp. ARKO

Arko Signs $230M M&A Deal with U.S. Petroleum Partners, LLC

ARKO Corp.'s majority-owned subsidiary, ARKO Petroleum Corp., completed the acquisition of U.S. Petroleum Partners, LLC for approximately $230 million, consisting of $200 million in cash and $30 million in APC Class A common stock. The acquired assets include two fuel terminals in Michigan and Ohio, a vehicle fleet, and fuel supply rights to approximately 400 dealer locations in the Great Lakes region.

Value
$230M
Counterparty
U.S. Petroleum Partners, LLC
6:15 AM ET 8-K
Clinical Trial Data enGene Therapeutics Inc. ENGN

enGene Therapeutics Clinical Trial Data

enGene Therapeutics announced results from the pivotal Cohort 1 of its Phase 2 LEGEND trial evaluating detalimogene in BCG-unresponsive non-muscle invasive bladder cancer. The company also reached alignment with the FDA on key components for its planned Biologics License Application (BLA) submission.

Counterparty
FDA
6:14 AM ET 8-K
Capital Raise Addentax Group Corp. ATXG

Addentax Group Capital Raise of $1.5M

Addentax Group Corp. entered into a private placement agreement with investor Chan Kai Fung to sell 312,500 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for general corporate purposes and working capital.

Value
$1.5M
Counterparty
Chan Kai Fung
6:14 AM ET 8-K
Divestiture Vylor Inc. VYLR

Vylor Divestiture

Vylor Inc. reported the completion of its separation from Corteva, Inc. into an independent, publicly traded company via a tax-free spin-off. The transaction was executed through a pro rata dividend in-kind of Vylor common stock to Corteva stockholders, with Vylor's shares commencing trading on the NYSE under the ticker 'VYLR' on October 1, 2026.

6:09 AM ET 8-K
M&A Deal Marinemax Inc HZO

Marinemax M&A Deal with Safe Harbor Marinas, LLC

MarineMax shareholders approved the previously announced merger agreement with affiliates of Safe Harbor Marinas, a portfolio company of Blackstone Infrastructure Partners. At a special meeting held on November 11, 2026, over 73% of outstanding shares were represented, with the vast majority voting in favor of the acquisition that will take the company private.

Counterparty
Safe Harbor Marinas, LLC
6:08 AM ET 8-K/A
M&A Deal Lisata Therapeutics, Inc. LSTA

Lisata Therapeutics M&A Deal with Marea Therapeutics, Inc.

Lisata Therapeutics filed an amendment to its previous 8-K to provide required audited financial statements and pro forma financial information following its completed acquisition of Marea Therapeutics, Inc. The filing includes combined financial statements for Marea and M2 Therapeutics for the years 2024 and 2025, as well as interim 2026 data.

Counterparty
Marea Therapeutics, Inc.
6:08 AM ET 8-K
Nasdaq/NYSE Compliance Notice AtlasClear Holdings, Inc. ATCH

AtlasClear Holdings Nasdaq/NYSE Compliance Notice

AtlasClear Holdings received notice from NYSE American that the exchange has suspended trading of its common stock and commenced delisting proceedings due to a low selling price. The company intends to appeal the determination and expects its stock to begin trading on the OTC Pink Limited Market on November 11, 2026.

Counterparty
NYSE American LLC
6:07 AM ET 8-K
Capital Raise Bluerock Acquisition Corp. II BRRK

Bluerock Acquisition Corp. II Capital Raise

Bluerock Acquisition Corp. II announced that holders of the 17,250,000 units sold in its initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting November 16, 2026. The units were originally issued in an IPO completed on September 28, 2026, and will continue to trade under the symbol 'BRRKU' if not separated.

6:03 AM ET 8-K
M&A Deal Liberty Capital Corp GLIBA

Liberty Capital M&A Deal with Q Gateway Ultimate Holdings, LLC

Liberty Capital's subsidiary GCI Holdings completed the acquisition of Quintillion, an Alaska-based fiber infrastructure provider with over 1,800 miles of subsea and terrestrial fiber. The parties entered into an amendment to the purchase agreement prior to closing to adjust cash targets, set-off $16.75 million for the Utqiagvik Terrestrial Route completion, and share variances in project costs. The deal unifies Alaska's fiber networks to improve routing diversity and service reliability across the state.

Counterparty
Q Gateway Ultimate Holdings, LLC
6:02 AM ET 8-K
M&A Deal Air Industries Group AIRI

Air Industries Group M&A Deal with Tenax Aerospace Acquisition, LLC

Air Industries Group received a letter from its merger partner, Tenax Aerospace Acquisition, LLC, claiming that proposed debt maturity extensions constitute a breach of their definitive merger agreement. Tenax has withheld consent for amendments to the company's subordinated notes and loan agreements, while Air Industries denies the claims and asserts the extensions are necessary to protect the company if the merger does not close by November 30, 2026.

Counterparty
Tenax Aerospace Acquisition, LLC
6:01 AM ET 8-K
M&A Deal Blue Owl Digital Infrastructure Trust

Blue Owl Digital Infrastructure Trust Signs $780M M&A Deal with US GCDC Phase 3 Holdings LP

Blue Owl Digital Infrastructure Trust completed the acquisition of a 54-megawatt data center facility in Gainesville, Virginia, for approximately $779.5 million. The property is 100% leased to a hyperscaler customer and was acquired through the purchase of 100% of the membership interests in GCDC Purchaser Phase 3 LLC. The deal was funded via available cash and a new $512.6 million secured mortgage loan from Citibank and Wells Fargo.

Value
$780M
Counterparty
US GCDC Phase 3 Holdings LP
6:01 AM ET 8-K
Divestiture NRG Energy, Inc. NRG

NRG Energy Divestiture to Orbit Acquisition Holdco, LLC for $4B

NRG Energy has entered into a definitive agreement to sell its interests in several power generation entities, including the Ravenswood and Ocean State Power facilities, to an affiliate of LS Power for $4.0 billion in cash. The transaction includes the sale of equity interests in nine subsidiaries and their respective holdings, subject to customary regulatory approvals from FERC and the New York State Public Service Commission.

Value
$4B
Counterparty
Orbit Acquisition Holdco, LLC
9:56 AM ET
Earnings Call Amprius Technologies, Inc. AMPX ▶ Call

Amprius Technologies Earnings Call: Key Takeaways

Amprius delivered record Q3 revenue of $39.1 million, raising full-year guidance for the third consecutive time while maintaining a capital-light contract manufacturing strategy for defense and aviation.

Call
Nov 11, 2026, 8:30 AM ET
6:32 PM ET
Earnings Call Rigetti Computing, Inc. RGTI ▶ Call

Rigetti Computing Earnings Call: Key Takeaways

Rigetti secured $100M in Department of Commerce funding, validating its chiplet-based superconducting roadmap while achieving 99.5% median two-qubit gate fidelity on its 108-qubit system.

Call
Nov 10, 2026, 5:00 PM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.